ArticleStem cell research & therapy2022

Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.

Hamid Reza Aghayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.